Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Revenue (2020 - 2025)

Biofrontera (BFRI) has 6 years of Revenue data on record, last reported at $7.0 million in Q3 2025.

  • For Q3 2025, Revenue fell 22.46% year-over-year to $7.0 million; the TTM value through Sep 2025 reached $37.2 million, up 5.1%, while the annual FY2024 figure was $37.3 million, 9.54% up from the prior year.
  • Revenue reached $7.0 million in Q3 2025 per BFRI's latest filing, down from $9.0 million in the prior quarter.
  • Across five years, Revenue topped out at $40.2 million in Q2 2022 and bottomed at $4.3 million in Q3 2022.
  • Average Revenue over 5 years is $9.7 million, with a median of $8.7 million recorded in 2023.
  • Peak YoY movement for Revenue: soared 587.43% in 2022, then tumbled 85.47% in 2023.
  • A 5-year view of Revenue shows it stood at $9.2 million in 2021, then increased by 10.65% to $10.1 million in 2022, then increased by 4.46% to $10.6 million in 2023, then rose by 18.53% to $12.6 million in 2024, then plummeted by 44.36% to $7.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Revenue were $7.0 million in Q3 2025, $9.0 million in Q2 2025, and $8.6 million in Q1 2025.